Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing β-catenin mRNA expression
- Bioorg Med Chem Lett. 2015 Sep 15;25(18):3937-40. doi: 10.1016/j.bmcl.2015.07.036.
- 1. Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.
- 2. Pharmacy Discipline, Life Science School, Khulna University, Khulna 9208, Bangladesh.
- 3. Department of Pharmaceutical Chemistry, University of Dhaka, Dhaka 1000, Bangladesh.
- 4. Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan. Electronic address: [email protected].
Four Alkaloids, voacangine (1), isovoacangine (2), coronaridine (3), and coronaridine hydroxyindolenine (4), were isolated from the MeOH extract of Tabernaemontana divaricata aerial parts by activity-guided fractionation for Wnt signal inhibitory activity. Compounds 1-4 exhibited TCF/β-catenin inhibitory activities with IC50 values of 11.5, 6.0, 5.8, and 7.3 μM, respectively. Of these, coronaridine (3) decreased β-catenin levels in SW480 colon Cancer cells, while this decrease in β-catenin was not suppressed by a co-treatment with 3 and MG132, a Proteasome Inhibitor. These results suggested that the decrease observed in β-catenin levels by coronaridine (3) did not depend on a proteasomal degradation process. On the Other hand, the treatment of SW480 cells with coronaridine (3) caused a decrease in β-catenin mRNA levels. Thus, coronaridine (3) may inhibit the Wnt signaling pathway by decreasing the mRNA expression of β-catenin.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Wnt